LexDanaLexDanabeta
Inventor

EDWARD HA

Inventor
US

Overview

3→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C07KPeptides22%
C12NMicroorganisms or enzymes11%
Y02ATechnologies for adaptation to climate change11%
PatentTitleYear
12,458,705Antibody-oligonucleotide conjugates202511,932,695Modified antibodies and related compounds, compositions and methods of use202411,229,711Linkers for antibody-drug conjugates and related compounds, compositions, and methods of use2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022Patents assigned to MAGENTA THERAPEUTICS INC (1)· patent assignee history
2022–2025Based in US· patent location history
2024Patents assigned to SENSEI BIOTHERAPEUTICS INC (1)· patent assignee history
2025Patents assigned to ANGIEX INC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ANGIEX INC12025
MAGENTA THERAPEUTICS INC12022
SENSEI BIOTHERAPEUTICS INC12024
Locations
LocationPatentsSpan
US32022–2025